Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05011890 · ClinicalTrials.gov registry record · NA
Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05011890 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 41 participants.
The verdict
NCT05011890, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate how Moovcare®, a mobile medical application, can be used to monitor Patient-Reported Outcomes (PROs) related to cancer treatment, cancer complications, and cancer relapse in patients with lung cancer. PROs are symptoms directly reported by patients through the completion of a survey. Up to 50 patients undergoing treatment and/or surveillance for new or existing diagnoses of lung cancer at the University of North Carolina's Lineberger Comprehensive Cancer Center will be prospectively enrolled to the use of the mobile medical application Moovcare® for 6 months. Moovcare® is not FDA approved, and its role in improving clinical care is being studied through this research. Moovcare® automatically delivers electronic patient reported outcome (ePRO) surveys on common symptoms experienced by lung cancer patients.
Interventions
- DEVICE Moovcare® use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05011890
The ClinicalTrials.gov registry entry for NCT05011890 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Moovcare® use is the first listed.
NCT05011890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05011890 about?
NCT05011890 is a clinical study titled "Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®". The purpose of this study is to demonstrate how Moovcare®, a mobile medical application, can be used to monitor Patient-Reported Outcomes (PROs) related to cancer treatment, cancer complications, and cancer relapse in patients with lung cancer. PROs are symptoms directly reported by patients through...
What is the current status of trial NCT05011890?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-09-01. Estimated completion is 2022-10-06.
What interventions are being tested in trial NCT05011890?
The interventions under investigation include: Moovcare® use (DEVICE).
Who is sponsoring clinical trial NCT05011890?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.